VAERS reports by lot

Merck HPV lot U019413: VAERS reports

20 VAERS reports list lot U019413 as a Merck HPV vaccine, received between 2022-04-05 and 2024-01-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
20
Reports
5%
Marked serious
0
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological620%
Injection-site / Local reaction620%
Gastrointestinal413%
Respiratory310%
Dermatological (non-injection-site)310%
General / Systemic (non-local)310%
Allergic / Anaphylactic27%
Musculoskeletal27%
Cardiac / Cardiovascular13%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey3
Texas2
New York2
Pennsylvania2
Oklahoma2
Alabama1
Georgia1
North Carolina1
Ohio1
Michigan1
Massachusetts1
Maine1

Reports by month received

2022-042
2022-051
2022-061
2022-072
2022-081
2022-091
2022-121
2023-013
2023-031
2023-041
2023-061
2023-071
2023-113
2024-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.